Table 4: Risk-of-bias assessment of the trials included in the meta-analysis*
TrialSequence generation (selection bias)Allocation concealment (selection bias)Blinding of participants and personnel (performance bias)Blinding of outcome assessors (detection bias)Completeness of outcome data (attrition bias)Selective reporting (reporting bias)Academic biasSponsor bias
ADOPT, 2006 (20) (26)LowLowLowLowLowLowLowHigh
Campbell et al., 1994 (27)UnclearUnclearHighHighLowUnclearLowUnclear
Collier et al., 1989 (28)UnclearUnclearHighHighUnclearUnclearLowHigh
DeFronzo et al., 1995 (29)UnclearUnclearUnclearUnclearUnclearUnclearLowHigh
Derosa et al., 2004 (42)UnclearUnclearHighHighLowUnclearLowUnclear
Hermann et al., 1991a (30)LowUnclearHighHighUnclearUnclearLowHigh
Hermann et al., 1991b (31) (34)LowLowLowLowLowLowHighHigh
Kamel et al., 1997 (35)UnclearUnclearUnclearUnclearUnclearUnclearLowUnclear
Lawrence et al., 2004 (36)UnclearUnclearHighLowLowUnclearLowHigh
Tang et al., 2004 (41)UnclearUnclearHighHighUnclearUnclearLowLow
Tessier et al., 1999 (37)UnclearUnclearHighHighLowUnclearLowHigh
Tosi et al., 2003 (38)LowLowLowLowUnclearLowLowHigh
UKPDS 34, 1998 (2), (39), (40)LowLowHighLowUnclearHighLowHigh
Yamanouchi et al., 2005 (43)LowLowHighHighLowUnclearLowUnclear

Note: ADOPT = A Diabetes Outcome Progression Trial, UKPDS = United Kingdom Prospective Diabetes Study.
*The Cochrane risk-of-bias tool was used to assess the risk of bias for each study. Low risk = bias, if present, is unlikely to alter the results seriously, unclear risk = bias raises some doubt about the results, high risk = bias may alter the results seriously. (10)